Banca Mediolanum (BMED) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 Jul, 2026Executive summary
Q1 2026 saw strong momentum with net income up 13% year-over-year to €276.2 million, operating margin up 25% to €350.1 million, and contribution margin up 18% to €581.9 million, despite increased market volatility and a complex macro environment.
Net commission income rose 12% to €353.5 million, net interest income surged 31% to €236.3 million, and total assets reached €154.37 billion, up 10% year-over-year.
Customer engagement and network expansion remained high, with 60,000 new clients added and strong recruitment of financial advisors.
Total net inflows were resilient at €3.34 billion, with managed asset inflows at €1.87 billion, despite market corrections.
The business model's resilience was evident, with relationship-based advisory and digital investments supporting growth.
Financial highlights
Net income: €276.2 million (+13% YoY); operating margin: €350.1 million (+25% YoY); contribution margin: €581.9 million (+18% YoY).
Net commission income: €353.5 million (+12% YoY), with management fees up 9% and banking service fees up 66%.
Net interest income: €236.3 million (+31% YoY), driven by lower funding costs and favorable funding mix.
Non-recurring items fell 42% to €29 million due to lower performance fees and negative fair value impacts.
Cost/income ratio improved to 34.8% from 37.6% in 2025.
Outlook and guidance
Net inflows into managed assets expected to reach around €9 billion for 2026, assuming stable markets.
Net interest income projected to rise by approximately 15% year-over-year.
Targeting a cost/income ratio of around 38% and cost of risk near 20 basis points.
Dividend per share expected to rise above the €0.80 base, subject to approval.
For 2027, net interest income is expected to grow between 5% and 8%.
Latest events from Banca Mediolanum
- June net inflows reached €951 million, with strong managed asset growth and new client gains.BMED
Trading update9 Jul 2026 - Net income up 6% to €477.3M, with record assets, strong inflows, and robust capital ratios.BMED
Q2 20259 Jul 2026 - Record net income and €10.44B inflows drive 42% dividend hike; 2025 inflows to stay strong.BMED
Q4 20248 Jul 2026 - Net income up 18% to €674.3M, assets at €133B, CET1 at 23.4%, interim dividend approved.BMED
Q3 20242 Jun 2026 - Net income up 24% to €449.9M, CET1 at 23.7%, and managed asset inflows guidance raised.BMED
Q2 20242 Jun 2026 - Net income up 10–10.4% YoY to €243.3m, with record inflows and strong capital ratios.BMED
Q1 20252 Jun 2026 - Record net income, strong asset growth, and a 25% higher dividend highlight a standout year.BMED
Q4 20253 Feb 2026 - Net income up 8% to €726M, assets at €150.4B, and interim dividend raised to €0.60/share.BMED
Q3 20258 Nov 2025